Yusuke Kanemasa

Yusuke Kanemasa

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.

A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: August 30, 2026

Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

Journal: Blood advances

Published: December 24, 2025

Single-cell transcriptomic profiling of platelet-adherent circulating tumor cells using a microcavity-gel manipulation platform.

Single-cell transcriptomic profiling of platelet-adherent circulating tumor cells using a microcavity-gel manipulation platform.

Journal: Journal of bioscience and bioengineering

Published: November 19, 2025

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.

Journal: Bone marrow transplantation

Published: July 26, 2025

Concurrent tumor lysis syndrome and 5-fluorouracil encephalopathy during the first cycle of zolbetuximab plus mFOLFOX6 for CLDN18.2-positive gastric cancer: a case report.

Concurrent tumor lysis syndrome and 5-fluorouracil encephalopathy during the first cycle of zolbetuximab plus mFOLFOX6 for CLDN18.2-positive gastric cancer: a case report.

Journal: International cancer conference journal

Published: July 07, 2025

Genetic prognostic markers in LymphGen-unclassifiable diffuse large B cell lymphoma.

Genetic prognostic markers in LymphGen-unclassifiable diffuse large B cell lymphoma.

Journal: International journal of hematology

Published: May 25, 2025

Site- and Stage-Adapted Treatment Strategies for Gastrointestinal Diffuse Large B-Cell Lymphoma.

Site- and Stage-Adapted Treatment Strategies for Gastrointestinal Diffuse Large B-Cell Lymphoma.

Journal: European journal of haematology

Published: April 10, 2025

Rapid Recovery and Short-Term Culture of Gastric Circulating Tumor Cells Using Microcavity Array.

Rapid Recovery and Short-Term Culture of Gastric Circulating Tumor Cells Using Microcavity Array.

Journal: Engineering in life sciences

Published: January 22, 2025

Correction to: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan.

Correction to: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan.

Journal: International journal of clinical oncology

Published: August 13, 2024

Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.

Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: June 26, 2024

Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report.

Management of HER2-positive and microsatellite instability-high advanced gastric cancer: a case report.

Journal: International cancer conference journal

Published: May 24, 2024

Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan.

Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan.

Journal: International journal of clinical oncology

Published: January 11, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026